Latest News

Three years after receiving Pilot Project Program funding from Women’s Health Research at Yale, Medical Oncologist and Investigator Pamela Kunz, MD, and her interdisciplinary research team completed a study that reveals important sex differences in neuroendocrine neoplasms (NENs).

Cristian C. Taborda, MD, is an assistant professor of medicine (medical oncology and hematology). He cares for patients with lymphoma as part of the Hematology Program at Smilow Cancer Hospital in New Haven and North Haven.

Barbara Burtness, MD, outlined the rationale behind OrigAMI-4 eligibility criteria and how tumor boards can select patients with HNSCC for amivantamab.

Barbara Burtness, MD, discussed strategies for managing skin reactions and MET-driven edema in head and neck cancer treated with subcutaneous amivantamab.

Barbara Burtness, MD, discussed the biological rationale for dual EGFR/MET targeting and how the OrigAMI-4 data may reshape treatment workflows for HNSCC.

Learning to engage in genuine, thoughtful dialogue is a powerful way to build trust and shared understanding across differences. It’s a skill especially important for those embarking on a career in healthcare where patient trust, team collaboration, and informed decision-making are paramount.

On July 30, 2026, Dr. Faye Rogers hosted the Biomedical Summer Undergraduate Research Fellowship Symposium.

In June, the Yale Cancer Center's Office of Collaborative Excellence celebrated the achievements of its trainees by hosting its inaugural End-of-Year Celebration, recognizing a year of scientific discovery and professional growth.

This summer, Yale Cancer Center's Cancer Research Training & Education Coordination (CRTEC) program welcomed the second cohort of the Future Deaf Scientists (FDS) Program, a four-week experience designed to introduce Deaf high school students to careers in cancer research, healthcare, and STEM.